| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0077 | 1 |